| 4D MOLECULAR THERAPEUTICS IN | COM | $875K | 0.1%Prev: 0.0% | 116,712 SH | Increased+100,000 SH |
| A SPAC III ACQUISITION CORP | RIGHT 01/02/2026 | $41K | 0.0%Prev: 0.0% | 215,000 SH | Decreased |
| AA MISSION ACQUISITION CORP | ORD SHS CL A | $10.5M | 0.8%Prev: 1.0% | 983,448 SH | Increased |
| ABIVAX SA | SPONSORED ADS | $177.6M | 13.0%Prev: 10.8% | 1,317,329 SH | Increased-33,497 SH |
| ACHIEVE LIFE SCIENCES INC | COM | $238K | 0.0%Prev: 0.0% | 47,800 SH | Increased |
| ACLARIS THERAPEUTICS INC | COM | $1.8M | 0.1%Prev: 0.1% | 613,986 SH | Increased+240,304 SH |
| ACUMEN PHARMACEUTICALS INC | COM | $1.9M | 0.1%Prev: 0.1% | 891,183 SH | Increased |
| ADAGIO MED HLDGS INC | COM | $1.2M | 0.1% | 1,159,614 SH | New |
| ADICET BIO INC | COM NEW | $1.1M | 0.1% | 128,646 SH | New |
| AGIOS PHARMACEUTICALS INC | COM | $5.1M | 0.4%Prev: 0.1% | 188,000 SH | Increased+151,000 SH |
| ALECTOR INC | COM | $1.7M | 0.1% | 1,108,000 SH | New |
| ALEXANDRIA REAL ESTATE EQ IN | COM | $798K | 0.1% | 16,300 SH | New |
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | $524K | 0.0%Prev: 0.1% | 3,578 SH | Decreased |
| ALKERMES PLC | SHS | $1.8M | 0.1%Prev: 0.2% | 63,700 SH | Increased+7,500 SH |
| AMERICAN EXCEPTIONALISM ACQU | ORD CL A | $4.1M | 0.3%Prev: 0.1% | 357,539 SH | Increased+307,539 SH |
| AMYLYX PHARMACEUTICALS INC | COM | $10.8M | 0.8%Prev: 1.1% | 890,356 SH | Decreased+24,154 SH |
| ANNEXON INC | COM | $241K | 0.0% | 48,000 SH | New |
| ANTERIS TECHNOLOGIES GLOBAL | COM | $6.2M | 0.5%Prev: 0.1% | 1,238,777 SH | Increased+1,041,162 SH |
| APELLIS PHARMACEUTICALS INC | COM | $502K | 0.0%Prev: 0.0% | 20,000 SH | Increased |
| AQUESTIVE THERAPEUTICS INC | COM | $1.6M | 0.1% | 254,000 SH | New |
| ARBUTUS BIOPHARMA CORP | COM | $26.0M | 1.9%Prev: 1.2% | 5,415,109 SH | Increased+2,511,883 SH |
| ARCELLX INC | COMMON STOCK | $2.1M | 0.2%Prev: 0.2% | 31,484 SH | Decreased |
| ARROWHEAD PHARMACEUTICALS IN | COM | $3.9M | 0.3%Prev: 0.2% | 58,200 SH | Increased+8,400 SH |
| ARS PHARMACEUTICALS INC | COM | $4.3M | 0.3%Prev: 0.1% | 369,569 SH | Increased+310,339 SH |
| ARVINAS INC | COM | $689K | 0.1%Prev: 0.1% | 58,091 SH | Decreased-24,500 SH |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $5.4M | 0.4%Prev: 0.7% | 25,314 SH | Decreased-11,031 SH |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $672K | 0.0%Prev: 0.0% | 19,747 SH | Increased+800 SH |
| ASTRAZENECA PLC | SPONSORED ADR | $827K | 0.1% | 9,000 SH | New |
| ASTRIA THERAPEUTICS INC | COM | $2.3M | 0.2%Prev: 0.1% | 173,557 SH | Increased-20,377 SH |
| ATAI BECKLEY NV | SHS | $3.7M | 0.3% | 913,242 SH | New |
| ATHIRA PHARMA INC | COM | $2.9M | 0.2% | 393,701 SH | New |
| ATYR PHARMA INC | COM NEW | $40K | 0.0%Prev: 0.0% | 50,685 SH | Decreased-431,615 SH |
| AURINIA PHARMACEUTICALS INC | COM | $351K | 0.0% | 22,000 SH | New |
| AVADEL PHARMACEUTICALS PLC | COM SHS | $3.2M | 0.2% | 150,532 SH | New |
| AVANTOR INC | COM | $802K | 0.1%Prev: 0.0% | 70,000 SH | Increased+45,000 SH |
| AVIDITY BIOSCIENCES INC | COM | $39.4M | 2.9%Prev: 0.2% | 546,534 SH | Increased+492,878 SH |
| BELITE BIO INC | SPONSORED ADS | $6.4M | 0.5% | 39,839 SH | New |
| BEST SPAC I ACQUISITION CORP | UNIT 05/27/2030 | $1.0M | 0.1%Prev: 0.1% | 100,000 SH | Increased |
| BICARA THERAPEUTICS INC | COM | $231K | 0.0%Prev: 0.0% | 13,705 SH | Increased |
| BIOAGE LABS INC | COM | $1.8M | 0.1%Prev: 1.0% | 135,560 SH | Decreased-1,744,513 SH |
| BIOATLA INC | COM | $104K | 0.0% | 183,107 SH | New |
| BIOCRYST PHARMACEUTICALS INC | COM | $351K | 0.0% | 45,000 SH | New |
| BIOGEN INC | COM | $4.3M | 0.3%Prev: 0.2% | 24,300 SH | Increased+6,300 SH |
| BIOHAVEN LTD | COM | $387K | 0.0%Prev: 0.1% | 34,277 SH | Decreased-15,064 SH |
| BIOMARIN PHARMACEUTICAL INC | COM | $767K | 0.1%Prev: 0.0% | 12,900 SH | Increased+8,000 SH |
| BIOMEA FUSION INC | COM | $54K | 0.0% | 43,420 SH | New |
| BIONTECH SE | SPONSORED ADS | $952K | 0.1%Prev: 0.1% | 10,000 SH | Decreased |
| BOSTON SCIENTIFIC CORP | COM | $477K | 0.0% | 5,000 SH | New |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $2.8M | 0.2%Prev: 0.5% | 226,248 SH | Decreased-274,980 SH |
| BRIDGEBIO PHARMA INC | COM | $16.3M | 1.2%Prev: 1.3% | 213,414 SH | Increased-60,000 SH |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $273K | 0.0% | 3,500 SH | New |
| BRIGHTHOUSE FINL INC | COM | $6.2M | 0.5%Prev: 0.0% | 95,523 SH | Increased+85,523 SH |
| BRISTOL-MYERS SQUIBB CO | COM | $1.1M | 0.1% | 20,000 SH | New |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $17.6M | 1.3%Prev: 0.3% | 646,767 SH | Increased+537,325 SH |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $965K | 0.1%Prev: 0.1% | 38,566 SH | Decreased-15,100 SH |
| CG ONCOLOGY INC | COM | $10.7M | 0.8%Prev: 0.9% | 258,139 SH | Increased+9,222 SH |
| CHEMOMAB THERAPEUTICS LTD | SPONSORED ADS | $132K | 0.0% | 80,000 SH | New |
| CHURCHILL CAP CORP X | SHS CL A | $1.0M | 0.1% | 64,887 SH | New |
| CIDARA THERAPEUTICS INC | COM NEW | $13.2M | 1.0%Prev: 0.2% | 59,677 SH | Increased+38,155 SH |
| CLEANCORE SOLUTIONS INC | CLASS B COM SHS | $136K | 0.0% | 521,980 SH | New |
| CLIMB BIO INC | COM | $5.7M | 0.4%Prev: 0.0% | 1,432,475 SH | Increased+1,298,945 SH |
| CLOVER HEALTH INVESTMENTS CO | COM CL A | $114K | 0.0%Prev: 0.0% | 48,300 SH | Decreased |
| COHEN CIRCLE ACQUISIT CORP I | UNIT 07/01/2030 | $1.6M | 0.1%Prev: 0.1% | 150,000 SH | Increased |
| COHERUS ONCOLOGY INC | COM | $15K | 0.0%Prev: 0.0% | 10,366 SH | Decreased |
| COMPASS THERAPEUTICS INC | COM | $746K | 0.1%Prev: 0.0% | 139,000 SH | Increased+89,000 SH |
| CONTEXT THERAPEUTICS INC | COM | $516K | 0.0%Prev: 0.0% | 351,094 SH | Increased |
| CONTINEUM THERAPEUTICS INC | CL A | $3.2M | 0.2%Prev: 0.1% | 278,961 SH | Increased+201,000 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $2.3M | 0.2%Prev: 0.0% | 286,781 SH | Increased+276,581 SH |
| CORE SCIENTIFIC INC NEW | COM | $437K | 0.0% | 30,000 SH | New |
| CORVUS PHARMACEUTICALS INC | COM | $3.6M | 0.3% | 465,875 SH | New |
| CRESCENT BIOPHARMA INC. | COM | $7.2M | 0.5% | 606,000 SH | New |
| CRINETICS PHARMACEUTICALS IN | COM | $14.4M | 1.1%Prev: 1.0% | 309,368 SH | Increased+61,000 SH |
| CULLINAN THERAPEUTICS INC | COM | $518K | 0.0% | 50,000 SH | New |
| CYBIN INC | COM NEW | $2.0M | 0.1%Prev: 0.0% | 238,390 SH | Increased+205,112 SH |
| CYTOKINETICS INC | COM NEW | $34.3M | 2.5%Prev: 2.7% | 540,166 SH | Increased+21,245 SH |
| CYTOMX THERAPEUTICS INC | COM | $18.2M | 1.3%Prev: 1.2% | 4,282,769 SH | Increased+237,355 SH |
| DANAHER CORPORATION | COM | $5.9M | 0.4% | 25,600 SH | New |
| DAYFORCE INC | COM | $346K | 0.0%Prev: 0.1% | 5,000 SH | Decreased-5,000 SH |
| DELCATH SYS INC | COM NEW | $2.3M | 0.2%Prev: 0.2% | 224,385 SH | Decreased |
| DENALI THERAPEUTICS INC | COM | $860K | 0.1%Prev: 0.1% | 52,116 SH | Increased+600 SH |
| DYNAVAX TECHNOLOGIES CORP | COM NEW | $2.6M | 0.2%Prev: 0.2% | 170,000 SH | Increased |
| DYNE THERAPEUTICS INC | COM | $1.0M | 0.1%Prev: 0.1% | 52,674 SH | Increased-4,989 SH |
| EA SERIES TRUST | ALPHA ARCH 1-3 | $38.8M | 2.8%Prev: 3.6% | 337,125 SH | Increased |
| EDGEWISE THERAPEUTICS INC | COM | $2.3M | 0.2%Prev: 0.1% | 90,999 SH | Increased+50,999 SH |
| ELANCO ANIMAL HEALTH INC | COM | $453K | 0.0% | 20,000 SH | New |
| ELECTRONIC ARTS INC | COM | $1.0M | 0.1%Prev: 0.1% | 4,936 SH | Increased |
| ELEDON PHARMACEUTICALS INC | COM | $2.8M | 0.2% | 1,821,812 SH | New |
| ENANTA PHARMACEUTICALS INC | COM | $652K | 0.0% | 41,357 SH | New |
| ENGENE HOLDINGS INC | COM | $2.7M | 0.2% | 303,686 SH | New |
| ENLIVEN THERAPEUTICS INC | COM | $462K | 0.0% | 30,000 SH | New |
| EQUILLIUM INC | COM | $8.7M | 0.6%Prev: 0.7% | 5,608,078 SH | Increased+48,090 SH |
| ESTABLISHMENT LABS HLDGS INC | COM | $12.5M | 0.9%Prev: 0.3% | 171,422 SH | Increased+80,734 SH |
| EVOLUS INC | COM | $238K | 0.0% | 35,859 SH | New |
| EVOMMUNE INC | COM SHS | $3.2M | 0.2% | 184,062 SH | New |
| FIBROGEN INC | COM NEW | $92K | 0.0% | 10,469 SH | New |
| FORWARD AIR CORP | COM | $666K | 0.0% | 26,635 SH | New |
| FRACTYL HEALTH INC | COM | $3.1M | 0.2%Prev: 0.0% | 1,428,571 SH | Increased+1,415,474 SH |
| FULCRUM THERAPEUTICS INC | COM | $14.9M | 1.1%Prev: 0.4% | 1,318,749 SH | Increased+902,137 SH |
| GENERATION BIO CO | COM NEW | $126K | 0.0%Prev: 0.0% | 22,144 SH | Decreased |
| GERON CORP | COM | $444K | 0.0%Prev: 0.1% | 336,176 SH | Decreased-120,000 SH |
| GILEAD SCIENCES INC | COM | $818K | 0.1% | 6,666 SH | New |
| GLOBA TERRA ACQUISITION COR | UNIT 99/99/9999 | $514K | 0.0%Prev: 0.0% | 50,000 SH | Increased |
| GLOBUS MED INC | CL A | $1.8M | 0.1% | 20,100 SH | New |
| GOSSAMER BIO INC | COM | $2.2M | 0.2%Prev: 0.1% | 710,831 SH | Increased+443,200 SH |
| GRACE THERAPEUTICS INC | COM | $2.2M | 0.2%Prev: 0.1% | 641,988 SH | Increased+291,538 SH |
| GUARDANT HEALTH INC | COM | $715K | 0.1%Prev: 0.0% | 7,000 SH | Increased+1,000 SH |
| IBIO INC | COM NEW | $783K | 0.1%Prev: 0.0% | 405,531 SH | Increased+378,531 SH |
| IDEAYA BIOSCIENCES INC | COM | $691K | 0.1%Prev: 0.1% | 20,000 SH | Increased |
| IDEXX LABS INC | COM | $271K | 0.0% | 400 SH | New |
| IMMIX BIOPHARMA INC | COM | $262K | 0.0% | 50,000 SH | New |
| IMMUNOVANT INC | COM | $63.1M | 4.6%Prev: 3.4% | 2,480,968 SH | Increased+239,215 SH |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $16.5M | 1.2%Prev: 0.8% | 8,063,949 SH | Increased+2,816,346 SH |
| INOVIO PHARMACEUTICALS INC | COM SHS | $2.7M | 0.2% | 1,560,508 SH | New |
| INSPIRE MED SYS INC | COM | $1.4M | 0.1%Prev: 0.0% | 15,000 SH | Increased+9,000 SH |
| INTUITIVE SURGICAL INC | COM NEW | $578K | 0.0% | 1,020 SH | New |
| INVENTIVA SA | ADS | $12.6M | 0.9% | 2,709,846 SH | New |
| INVIVYD INC | COM | $9.6M | 0.7%Prev: 0.8% | 3,899,397 SH | Increased-3,471,590 SH |
| INVO FERTILITY INC. | COM | $20K | 0.0% | 26,722 SH | New |
| IO BIOTECH INC | COM | $15K | 0.0% | 24,964 SH | New |
| IONIS PHARMACEUTICALS INC | COM | $11.6M | 0.9%Prev: 0.8% | 147,130 SH | Increased+13,312 SH |
| ISHARES TR | RUSSELL 2000 ETF | $9.7M | 0.7% | 39,570 SH | New |
| JADE BIOSCIENCES INC | COM NEW | $324K | 0.0% | 21,000 SH | New |
| JANUX THERAPEUTICS INC | COM | $3.4M | 0.2%Prev: 0.8% | 245,452 SH | Decreased-105,580 SH |
| JASPER THERAPEUTICS INC | COM NEW | $256K | 0.0% | 140,000 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $1.4M | 0.1%Prev: 0.0% | 8,000 SH | Increased+5,500 SH |
| JD.COM INC | SPON ADS CL A | $287K | 0.0%Prev: 0.0% | 10,000 SH | Decreased |
| KALA BIO INC | COM NEW | $79K | 0.0%Prev: 0.0% | 141,480 SH | Decreased-515 SH |
| KALARIS THERAPEUTICS INC | COM | $844K | 0.1% | 100,000 SH | New |
| KALVISTA PHARMACEUTICALS INC | COM | $162K | 0.0%Prev: 0.0% | 10,000 SH | Increased |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $368K | 0.0%Prev: 0.0% | 50,000 SH | Increased+25,000 SH |
| KEEN VISION ACQUISITION CORP | SHS | $881K | 0.1%Prev: 0.1% | 75,000 SH | Increased |
| KEROS THERAPEUTICS INC | COM | $384K | 0.0%Prev: 8.0% | 18,851 SH | Decreased-5,370,413 SH |
| KEZAR LIFE SCIENCES INC | COM NEW | $739K | 0.1%Prev: 0.0% | 117,440 SH | Increased-7,527 SH |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | $1.2M | 0.1%Prev: 0.3% | 28,728 SH | Decreased-46,459 SH |
| KIORA PHARMACEUTICALS INC | COM | $331K | 0.0%Prev: 0.0% | 167,941 SH | Decreased |
| KRYSTAL BIOTECH INC | COM | $4.9M | 0.4%Prev: 0.3% | 20,014 SH | Increased+1,491 SH |
| KURA ONCOLOGY INC | COM | $416K | 0.0%Prev: 0.0% | 40,000 SH | Decreased-15,000 SH |
| KYVERNA THERAPEUTICS INC | COM | $540K | 0.0% | 57,428 SH | New |
| LARIMAR THERAPEUTICS INC | COM | $707K | 0.1%Prev: 0.1% | 185,689 SH | Decreased-50,000 SH |
| LEXEO THERAPEUTICS INC | COM | $13.8M | 1.0%Prev: 1.0% | 1,393,161 SH | Increased-138,792 SH |
| LIQUIDIA CORPORATION | COM NEW | $845K | 0.1% | 24,500 SH | New |
| LITE STRATEGY INC | COM | $89K | 0.0%Prev: 0.1% | 67,292 SH | Decreased-225,105 SH |
| MADRIGAL PHARMACEUTICALS INC | COM | $521K | 0.0%Prev: 0.2% | 895 SH | Decreased-4,000 SH |
| MASIMO CORP | COM | $2.0M | 0.1%Prev: 0.2% | 15,000 SH | Decreased |
| MAZE THERAPEUTICS INC | COM | $7.4M | 0.5%Prev: 0.1% | 179,532 SH | Increased+153,487 SH |
| MCKESSON CORP | COM | $984K | 0.1% | 1,200 SH | New |
| MERCK & CO INC | COM | $1.0M | 0.1%Prev: 0.1% | 9,640 SH | Decreased-8,900 SH |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | $63K | 0.0% | 150,000 SH | New |
| MILESTONE PHARMACEUTICALS IN | COM | $202K | 0.0% | 100,100 SH | New |
| MINERALYS THERAPEUTICS INC | COM | $4.9M | 0.4%Prev: 0.3% | 136,231 SH | Increased+57,993 SH |
| MONOPAR THERAPEUTICS INC | COM NEW | $15.3M | 1.1%Prev: 1.0% | 233,908 SH | Increased+103,909 SH |
| MONTE ROSA THERAPEUTICS INC | COM | $3.4M | 0.2%Prev: 0.2% | 215,752 SH | Increased |
| NATERA INC | COM | $492K | 0.0% | 2,147 SH | New |
| NEKTAR THERAPEUTICS | COM NEW | $3.0M | 0.2%Prev: 0.4% | 72,031 SH | Decreased+24 SH |
| NEUMORA THERAPEUTICS INC. | COM | $91K | 0.0% | 50,600 SH | New |
| NEUPHORIA THERAPEUTICS INC | COM | $116K | 0.0% | 30,000 SH | New |
| NEUROGENE INC | COM | $631K | 0.0%Prev: 0.0% | 30,633 SH | Increased |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $4.2M | 0.3%Prev: 0.3% | 118,623 SH | Increased+4,264 SH |
| NOVOCURE LTD | ORD SHS | $440K | 0.0%Prev: 0.1% | 34,000 SH | Decreased-30,000 SH |
| NURIX THERAPEUTICS INC | COM | $1.4M | 0.1%Prev: 0.0% | 72,070 SH | Increased+40,870 SH |
| NUVALENT INC | COM | $688K | 0.1%Prev: 0.1% | 6,842 SH | Decreased-5,000 SH |
| OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | $5.5M | 0.4%Prev: 0.5% | 516,482 SH | Increased |
| OLEMA PHARMACEUTICALS INC | COM | $2.0M | 0.1%Prev: 0.1% | 81,399 SH | Increased+20,199 SH |
| OMEROS CORP | COM | $1.7M | 0.1% | 100,000 SH | New |
| OMNIAB INC | COM | $1.3M | 0.1%Prev: 0.2% | 702,190 SH | Decreased-388,438 SH |
| ONKURE THERAPEUTICS INC | COM CL A | $2.9M | 0.2% | 1,014,158 SH | New |
| OPUS GENETICS INC | COM | $80K | 0.0% | 40,000 SH | New |
| ORGANON & CO | COMMON STOCK | $251K | 0.0%Prev: 0.0% | 35,000 SH | Increased+25,000 SH |
| ORTHOPEDIATRICS CORP | COM | $352K | 0.0% | 19,845 SH | New |
| ORUKA THERAPEUTICS INC | COM | $632K | 0.0%Prev: 0.0% | 20,840 SH | Increased |
| OUTLOOK THERAPEUTICS INC | COM | $158K | 0.0% | 100,000 SH | New |
| OVID THERAPEUTICS INC | COM | $7.0M | 0.5%Prev: 0.0% | 4,285,000 SH | Increased+4,272,154 SH |
| PALISADE BIO INC | COM | $4.7M | 0.3% | 2,004,845 SH | New |
| PEPGEN INC | COM | $240K | 0.0%Prev: 0.0% | 36,842 SH | Increased |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | $6.0M | 0.4%Prev: 0.7% | 456,720 SH | Decreased-293,280 SH |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $262K | 0.0% | 95,193 SH | New |
| PFIZER INC | COM | $1.8M | 0.1%Prev: 0.1% | 72,400 SH | Increased+28,000 SH |
| PHARVARIS N V | COM | $2.4M | 0.2%Prev: 0.1% | 85,528 SH | Increased+51,404 SH |
| PHATHOM PHARMACEUTICALS INC | COM | $712K | 0.1%Prev: 0.0% | 42,900 SH | Increased |
| PLIANT THERAPEUTICS INC | COM | $90K | 0.0% | 73,819 SH | New |
| PLYMOUTH INDL REIT INC | COM | $899K | 0.1% | 41,065 SH | New |
| PMV PHARMACEUTICALS INC | COM | $126K | 0.0%Prev: 0.0% | 101,008 SH | Decreased |
| POLYPID LTD | COM | $451K | 0.0% | 103,950 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $442K | 0.0% | 1,500 SH | New |
| PROCAP ACQUISITION CORP | UNIT 05/16/2030 | $276K | 0.0%Prev: 0.0% | 26,940 SH | Decreased |
| PROQR THRAPEUTICS N V | SHS EURO | $20K | 0.0%Prev: 0.0% | 10,000 SH | Decreased |
| PROTAGONIST THERAPEUTICS INC | COM | $91.6M | 6.7%Prev: 6.2% | 1,049,168 SH | Increased+59,986 SH |
| PROTARA THERAPEUTICS INC | COM STK | $6.1M | 0.4%Prev: 0.0% | 1,136,799 SH | Increased+1,101,576 SH |
| PROTHENA CORP PLC | SHS | $13.9M | 1.0%Prev: 1.3% | 1,457,764 SH | Decreased-11,334 SH |
| PULMONX CORP | COM | $785K | 0.1%Prev: 0.0% | 355,410 SH | Increased+140,913 SH |
| Q32 BIO INC | COM | $66K | 0.0% | 20,000 SH | New |
| QUINCE THERAPEUTICS INC | COM | $412K | 0.0%Prev: 0.1% | 122,912 SH | Decreased-652,122 SH |
| QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | $840K | 0.1% | 58,230 SH | New |
| RAPT THERAPEUTICS INC | COM NEW | $17.3M | 1.3%Prev: 1.2% | 509,679 SH | Increased+1,908 SH |
| RECURSION PHARMACEUTICALS IN | CL A | $143K | 0.0%Prev: 0.0% | 35,000 SH | Decreased |
| REGENERON PHARMACEUTICALS | COM | $9.3M | 0.7%Prev: 0.8% | 12,051 SH | Increased-3,649 SH |
| REGENXBIO INC | COM | $2.1M | 0.2%Prev: 0.2% | 144,848 SH | Increased-60,561 SH |
| RELMADA THERAPEUTICS INC | COM | $149K | 0.0% | 30,866 SH | New |
| REPLIMUNE GROUP INC | COM | $12.3M | 0.9%Prev: 0.4% | 1,266,322 SH | Increased+237,428 SH |
| REVOLUTION MEDICINES INC | COM | $11.6M | 0.8%Prev: 0.6% | 145,079 SH | Increased+5,943 SH |
| REZOLUTE INC | COM NEW | $91K | 0.0%Prev: 0.7% | 38,679 SH | Decreased-777,296 SH |
| RHYTHM PHARMACEUTICALS INC | COM | $5.5M | 0.4%Prev: 0.5% | 51,349 SH | Increased+1,778 SH |
| ROCKET PHARMACEUTICALS INC | COM | $1.7M | 0.1%Prev: 0.2% | 475,800 SH | Decreased-100,000 SH |
| ROIVANT SCIENCES LTD | SHS | $74.4M | 5.5%Prev: 4.8% | 3,428,962 SH | Increased+81,461 SH |
| RXSIGHT INC | COM | $227K | 0.0% | 21,803 SH | New |
| SAB BIOTHERAPEUTICS INC | COM NEW | $99K | 0.0%Prev: 0.0% | 26,344 SH | Increased+11,344 SH |
| SANOFI SA | SPONSORED ADR | $3.1M | 0.2%Prev: 0.3% | 63,474 SH | Decreased-10,738 SH |
| SAREPTA THERAPEUTICS INC | COM | $621K | 0.0%Prev: 0.6% | 28,866 SH | Decreased-320,941 SH |
| SAVARA INC | COM | $8.5M | 0.6%Prev: 0.7% | 1,405,452 SH | Increased-582,836 SH |
| SCHOLAR ROCK HLDG CORP | COM | $3.1M | 0.2%Prev: 0.1% | 69,589 SH | Increased+49,502 SH |
| SEPTERNA INC | COM | $32.3M | 2.4%Prev: 2.1% | 1,157,611 SH | Increased-18,880 SH |
| SILENCE THERAPEUTICS PLC | ADS | $144K | 0.0%Prev: 0.0% | 23,643 SH | Increased+5,000 SH |
| SOLENO THERAPEUTICS INC | COM | $1.9M | 0.1%Prev: 0.2% | 41,830 SH | Increased+16,600 SH |
| SOLIDION TECHNOLOGY INC | COM NEW | $96K | 0.0%Prev: 0.0% | 13,500 SH | Increased |
| SPDR S&P 500 ETF TR | TR UNIT | $37.3M | 2.7%Prev: 6.3% | 54,684 SH | Decreased-45,500 SH |
| SPDR SERIES TRUST | STATE STREET SPD | $12.4M | 0.9% | 135,585 SH | New |
| SPERO THERAPEUTICS INC | COM | $265K | 0.0%Prev: 0.0% | 113,839 SH | Increased-1,700 SH |
| SPRUCE BIOSCIENCES INC | COM NEW | $5.1M | 0.4% | 58,000 SH | New |
| SPYRE THERAPEUTICS INC | COM NEW | $1.1M | 0.1%Prev: 0.1% | 34,051 SH | Increased |
| SUMMIT THERAPEUTICS INC | COM | $1.6M | 0.1%Prev: 0.2% | 91,869 SH | Decreased-11,100 SH |
| SUPERNUS PHARMACEUTICALS INC | COM | $1.5M | 0.1%Prev: 0.1% | 29,742 SH | Increased+15,324 SH |
| SURGERY PARTNERS INC | COM | $309K | 0.0%Prev: 0.0% | 20,000 SH | Decreased |
| SUTRO BIOPHARMA INC | COM SHS | $776K | 0.1% | 67,077 SH | New |
| SYNDAX PHARMACEUTICALS INC | COM | $252K | 0.0% | 12,000 SH | New |
| TANGO THERAPEUTICS INC | COM | $1.2M | 0.1% | 140,021 SH | New |
| TAYSHA GENE THERAPIES INC | COM SHS | $13.7M | 1.0%Prev: 0.9% | 2,495,809 SH | Increased-339,871 SH |
| TECTONIC THERAPEUTIC INC | COM | $626K | 0.0%Prev: 0.1% | 30,007 SH | Decreased-26,000 SH |
| TELEFLEX INCORPORATED | COM | $9.8M | 0.7% | 80,627 SH | New |
| TENAX THERAPEUTICS INC | COM NEW | $776K | 0.1%Prev: 0.0% | 63,673 SH | Increased+10,245 SH |
| TENAYA THERAPEUTICS INC | COM | $1.1M | 0.1% | 1,505,300 SH | New |
| TERNS PHARMACEUTICALS INC | COM | $21.9M | 1.6%Prev: 0.0% | 541,615 SH | Increased+531,615 SH |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | $7.4M | 0.5%Prev: 0.5% | 235,971 SH | Increased-31,845 SH |
| THERAPEUTICSMD INC | COM NEW | $341K | 0.0%Prev: 0.0% | 209,210 SH | Increased |
| TRAWS PHARMA INC | COM NEW | $175K | 0.0% | 154,431 SH | New |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $230K | 0.0%Prev: 0.0% | 10,000 SH | Decreased+1,000 SH |
| UNIQURE NV | SHS | $6.3M | 0.5%Prev: 1.8% | 265,155 SH | Decreased-68,161 SH |
| UNITED THERAPEUTICS CORP DEL | COM | $926K | 0.1%Prev: 0.4% | 1,900 SH | Decreased-9,300 SH |
| UROGEN PHARMA LTD | COM | $3.9M | 0.3%Prev: 0.1% | 165,375 SH | Increased+90,375 SH |
| VAXCYTE INC | COM | $14.6M | 1.1%Prev: 0.7% | 315,642 SH | Increased+102,578 SH |
| VENTYX BIOSCIENCES INC | COM | $737K | 0.1%Prev: 0.0% | 81,600 SH | Increased |
| VERA THERAPEUTICS INC | CL A | $746K | 0.1% | 14,733 SH | New |
| VERTEX PHARMACEUTICALS INC | COM | $6.2M | 0.5%Prev: 0.3% | 13,716 SH | Increased+6,716 SH |
| VERU INC | COM NEW | $75K | 0.0% | 35,000 SH | New |
| VIKING THERAPEUTICS INC | COM | $932K | 0.1%Prev: 0.4% | 26,494 SH | Decreased-149,425 SH |
| VIRIDIAN THERAPEUTICS INC | COM | $2.4M | 0.2%Prev: 0.2% | 77,198 SH | Increased-24,506 SH |
| VISTAGEN THERAPEUTICS INC | COM | $492K | 0.0%Prev: 0.0% | 743,575 SH | Increased+630,513 SH |
| VOYAGER THERAPEUTICS INC | COM | $138K | 0.0%Prev: 0.0% | 35,000 SH | Decreased |
| VYNE THERAPEUTICS INC | COM | $147K | 0.0% | 253,791 SH | New |
| WHITEHAWK THERAPEUTICS INC | COM | $188K | 0.0% | 77,593 SH | New |
| WISDOMTREE TR | FLOATNG RAT TREA | $503K | 0.0%Prev: 0.0% | 10,000 SH | Increased |
| WW INTL INC | COM NEW | $1.7M | 0.1%Prev: 0.1% | 57,100 SH | Increased+4,650 SH |
| XENCOR INC | COM | $860K | 0.1%Prev: 0.1% | 56,165 SH | Decreased-72,700 SH |
| XENON PHARMACEUTICALS INC | COM | $9.1M | 0.7%Prev: 0.7% | 203,969 SH | Increased+14,871 SH |
| ZAI LAB LTD | ADR | $22.0M | 1.6%Prev: 2.8% | 1,246,520 SH | Decreased+377,740 SH |
| ZENTALIS PHARMACEUTICALS INC | COM | $108K | 0.0%Prev: 0.0% | 80,000 SH | Increased+30,000 SH |
| ZURA BIO LTD | CLASS A ORD SHS | $2.9M | 0.2%Prev: 0.3% | 562,065 SH | Increased-90,089 SH |